Detection of HTLV-II-seropositive Blood Donors in South Vietnam but Not in North Vietnam

Overview

Journal Jpn J Cancer Res

Specialty Oncology

Date 1994 Sep 1

PMID 7961112

Citations 2

Authors

S Yamamoto

S Nakata

T Nakasone

T Chosa

P Song

D D Duc

B Hien

N X Quang

T N Trinh

T Ono

Affiliations

Soon will be listed here.

Abstract

Approximately 1% (4/500) of blood donors exhibited seropositivity for HTLV-II in South Vietnam, but none (0/500) did in North Vietnam. Further, all individuals seropositive for HTLV-II were intravenous drug abusers who were seronegative for HIV-1 and HTLV-I. These findings suggest that HTLV-II infection may be specifically prevalent in drug abusers in South Vietnam.

Citing Articles

Nucleotide sequence variation of human T-lymphotropic virus type II in Vietnam.

Yoshizaki H, Nakasone T, Nakasatomi T, Kusagawa S, Sato H, Nguyen T Jpn J Cancer Res. 1997; 88(9):787-91.

PMID: 9369924 PMC: 5921508. DOI: 10.1111/j.1349-7006.1997.tb00452.x.

Human T-lymphotropic virus type II in Japan.

Yoshizaki H, Kitamura K, Oki A, Yahara S, Yamanaka R, Fukushima Y Jpn J Cancer Res. 1996; 87(1):1-4.

PMID: 8609039 PMC: 5920975. DOI: 10.1111/j.1349-7006.1996.tb00191.x.

References

FUJINO R, Kawato K, Ikeda M, Miyakoshi H, Mizukoshi M, Imai J . Improvement of gelatin particle agglutination test for detection of anti-HTLV-I antibody. Jpn J Cancer Res. 1991; 82(4):367-70. PMC: 5918434. DOI: 10.1111/j.1349-7006.1991.tb01856.x. View

Jacobson S, LEHKY T, Nishimura M, Robinson S, McFarlin D, Dhib-Jalbut S . Isolation of HTLV-II from a patient with chronic, progressive neurological disease clinically indistinguishable from HTLV-I-associated myelopathy/tropical spastic paraparesis. Ann Neurol. 1993; 33(4):392-6. DOI: 10.1002/ana.410330411. View

Lee H, Weiss S, Brown L, Mildvan D, Shorty V, Saravolatz L . Patterns of HIV-1 and HTLV-I/II in intravenous drug abusers from the middle atlantic and central regions of the USA. J Infect Dis. 1990; 162(2):347-52. DOI: 10.1093/infdis/162.2.347. View

Khabbaz R, Hartel D, Lairmore M, Horsburgh C, Schoenbaum E, Roberts B . Human T lymphotropic virus type II (HTLV-II) infection in a cohort of New York intravenous drug users: an old infection?. J Infect Dis. 1991; 163(2):252-6. DOI: 10.1093/infdis/163.2.252. View

Honda M, Kitamura K, Nakasone T, Fukushima Y, Matsuda S, Nishioka K . Japanese patients with chronic fatigue syndrome are negative for known retrovirus infections. Microbiol Immunol. 1993; 37(10):779-84. DOI: 10.1111/j.1348-0421.1993.tb01705.x. View

Lal R, Heneine W, Rudolph D, Present W, Hofhienz D, Hartley T . Synthetic peptide-based immunoassays for distinguishing between human T-cell lymphotropic virus type I and type II infections in seropositive individuals. J Clin Microbiol. 1991; 29(10):2253-8. PMC: 270308. DOI: 10.1128/jcm.29.10.2253-2258.1991. View

Hall W, Takahashi H, Liu C, Kaplan M, Scheewind O, Ijichi S . Multiple isolates and characteristics of human T-cell leukemia virus type II. J Virol. 1992; 66(4):2456-63. PMC: 289041. DOI: 10.1128/JVI.66.4.2456-2463.1992. View

Cartier L, Araya F, Castillo J, Zaninovic V, Hayami M, Miura T . Southernmost carriers of HTLV-I/II in the world. Jpn J Cancer Res. 1993; 84(1):1-3. PMC: 5919034. DOI: 10.1111/j.1349-7006.1993.tb02774.x. View

Hjelle B, Zhu S, Takahashi H, Ijichi S, Hall W . Endemic human T cell leukemia virus type II infection in southwestern US Indians involves two prototype variants of virus. J Infect Dis. 1993; 168(3):737-40. DOI: 10.1093/infdis/168.3.737. View

10.

Calabro M, Luparello M, Grottola A, Del Mistro A, Fiore J, Angarano G . Detection of human T lymphotropic virus type II/b in human immunodeficiency virus type 1-coinfected persons in southeastern Italy. J Infect Dis. 1993; 168(5):1273-7. DOI: 10.1093/infdis/168.5.1273. View

11.

Lairmore M, Jacobson S, Gracia F, De B, Castillo L, Larreategui M . Isolation of human T-cell lymphotropic virus type 2 from Guaymi Indians in Panama. Proc Natl Acad Sci U S A. 1990; 87(22):8840-4. PMC: 55055. DOI: 10.1073/pnas.87.22.8840. View

12.

Heneine W, Kaplan J, Gracia F, Lal R, Roberts B, Levine P . HTLV-II endemicity among Guaymi Indians in Panama. N Engl J Med. 1991; 324(8):565. DOI: 10.1056/NEJM199102213240815. View

13.

Fujiyama C, Fujiyoshi T, Miura T, Yashiki S, Matsumoto D, Zaninovic V . A new endemic focus of human T lymphotropic virus type II carriers among Orinoco natives in Colombia. J Infect Dis. 1993; 168(4):1075-7. DOI: 10.1093/infdis/168.4.1075. View

14.

Yoshida T, Matsui T, Kobayashi S, Harada S, Kurimura T, Hinuma Y . A novel agglutination test for the human immunodeficiency virus antibody: a comparative study with enzyme-linked immunosorbent assay and immunofluorescence. Jpn J Cancer Res. 1986; 77(12):1211-3. View

15.

Igarashi T, Yamashita M, Miura T, Osei-Kwasi M, Aysi N, Shiraki H . Isolation and genomic analysis of human T lymphotropic virus type II from Ghana. AIDS Res Hum Retroviruses. 1993; 9(10):1039-42. DOI: 10.1089/aid.1993.9.1039. View

16.

Takahashi H . [Molecular characterization of human T-cell lymphotrophic virus type II]. Hokkaido Igaku Zasshi. 1993; 68(4):485-95. View

17.

Hjelle B, Mills R, Swenson S, Mertz G, Key C, Allen S . Incidence of hairy cell leukemia, mycosis fungoides, and chronic lymphocytic leukemia in first known HTLV-II-endemic population. J Infect Dis. 1991; 163(3):435-40. DOI: 10.1093/infdis/163.3.435. View

18.

Lipka J, Miyoshi I, Hadlock K, Reyes G, Chow T, Blattner W . Segregation of human T cell lymphotropic virus type I and II infections by antibody reactivity to unique viral epitopes. J Infect Dis. 1992; 165(2):268-72. DOI: 10.1093/infdis/165.2.268. View

19.

Kalyanaraman V, Sarngadharan M, Robert-Guroff M, Miyoshi I, Golde D, Gallo R . A new subtype of human T-cell leukemia virus (HTLV-II) associated with a T-cell variant of hairy cell leukemia. Science. 1982; 218(4572):571-3. DOI: 10.1126/science.6981847. View